Lexaria Biosciences Corp. (LXRP) is ready for the cannabis boom to come.
The Canadian firm has carved a space for itself in food sciences by developing cutting-edge infusion techniques that could play a major role as legal cannabis continues to gain traction.
While the company focuses on a number of lipid infusion technologies, its work in cannabis has taken the spotlight. Lexaria is working on high-tech delivery means that it will later sell to companies as an R&D leader and licensing firm. Here's what Lexaria director Chris Bunka told TheStreet at the LD Micro conference in Los Angeles.
For more from the LD Micro Conference in La:
TheStreet at LD Micro: What CEO Dave Callaway Sees in Small Caps This Year
STK Owner The ONE Group Is Carving Its Own Unique Space in the Dining Experience
SRAX Chief Weighs in as Company Readies for Cryptocurrency Dividend
Snap Interactive's New Blockchain App Could Flip Video Chat on Its Head
Micro Caps Take the Spotlight at LD Micro Conference - Here's What to Expect
Here's How Cloud Computing Firm Fusion Is Using M&A to Get Ahead
Biotech Innovator Oncolix Utilizing Novel Treatment to End Women's Cancers
Amazing Energy Isn't Afraid to Take on Big Oil